This medication is used to treat a type of multiple sclerosis that occurs when symptoms appear in cycles of worsening and improvement (relapsing/remitting multiple sclerosis-MS). It is not a cure for MS, but it is thought to help by preventing your immune system from attacking the nerves in your brain and spinal cord. It helps decrease the number of episodes of worsening and may prevent or delay disability.
Natalizumab...
Read moreAlthough the June 2010 ruling by the California state appeals court graced my desk nearly a month ago, I've needed time to calm down to put... Read more »
Tysabri, a drug initially used to treat Multiple Sclerosis has been approved for use in certain patients with Crohn's disease. This drug is... Read more »
An article in the August 1 edition of The Wall Street Journal reports that two patients treated with Tysabri have contracted progressive... Read more »
Our thoughts are with the patients and families in Europe who recently developed PML (Progressive Multifocal Leukoencephalopathy) on... Read more »
Tysabri has been in the news again this week. Last Friday the European Medicines Agency (EMEA) announced that they would review the... Read more »
The U.S. Food and Drug Administration has updated the safety information for the drug Tysabri to take into account the incidence of a rare brain... Read more »
The U.S. Food and Drug Administration has placed a new warning label on the multiple sclerosis (MS) drug Tysabri, one that warns doctors and patients... Read more »
According to a new study, Tysabri significantly increases the proportion of disease-free patients with relapsing multiple sclerosis (MS) compared... Read more »
:Refractory Migraines — Migraines that are not responding to treatment — can present significant issues for Migraineurs, including status... Read more »